Seqanswers Leaderboard Ad

Collapse

Announcement

Collapse
No announcement yet.
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • pmiguel
    replied
    Originally posted by bertgold View Post
    I am using 0.05 microliters big dye per well in 384 well plate.
    Ah, up-thread you wrote:

    I am using 2 microliter reactions for big dye in a 384 well plate

    So I presumed you meant 2ul of Big Dye (1/4th) reactions. But you must have meant 2ul total volume reactions and 1/160th reactions. I don't know what you are paying in CleanSeq, but you say it is more than the 4 cents you pay in Big Dye. I am going to guess that it is at least 6 cents. So you still have polymer, capillary and service contract costs. Even with preferential government pricing on your instrument service contracts I guess you are looking at near $20K/year per sequencer. Call it $50/ day or another $0.04/reaction.

    Well, to spare everyone the rest of the blow-by-blow I think it is safe to say that you are looking at costs of at least $0.20/reaction. So, let's call this $0.20 per 1E-03 bases or $200/megabase of raw sequence. This puts you at least 1 order of magnitude above the cost of a GS-FLX or Ion Torrent data set of the same size. And that means an Illumina data set of the same size would run you 2 orders of magnitude less.

    Which is not to say that Sanger sequence will not get you the most bang for your particular buck. But given the level of optimization you have gone to for Sanger, my guess is that you would have little difficulty re-tooling for a Next Generation protocol that would drop your costs 10x, if not more. I hasten to add that I am not saying it would be easy, but for you I doubt it would be hard. Although change is frequently painful, you might as well get used to the current sequencing paradigms, if you have a choice.


    --
    Phillip

    Leave a comment:


  • pmiguel
    replied
    Originally posted by bertgold View Post
    It occurs to me that you probably centrifuge and aspirate the Ethanol. That will not work for the throughputs we are using.

    Yes, the CleanSeq at $ 20,000 per liter (appoximately) is far more expensive than the big dye per reaction.
    Actually we just do inverted spins to remove the ethanol. However we do use a 6K RPM plate centrifuge for the precipitation spin. The protocol is nothing special. The only changes that were critical were reducing the sodium acetate concentration 1000x (probably no different than adding only ethanol to the precipitation) and using somewhat less than 2 volumes of ethanol. The former aids electrokinetic injection of product and the latter helps with signal droop.

    But I admit this may not scale well. To tell you the truth, Sanger sequencing is so obviously trailing edge at this point, I just can't find the motivation to continue to tinker with it. At this point I just "put out fires" but otherwise leave the technique as is.

    --
    Phillip

    Leave a comment:


  • pmiguel
    replied
    Originally posted by bertgold View Post
    Incidentally, I resent this web site's assertion that I am a 'junior' member. I am 57 years old with more than 30 years of experience. I would hardly call myself 'junior'.
    That is just the default. You should be able to edit your profile and put whatever you want in there. Go to the left top corner of a page and click "User CP". This stands for "User Control Panel". Then click "Edit Your Details". If you edit the "Custom User Title" box, you can change the "Junior Member" title that is the source of your resentment.

    --
    Phillip
    Last edited by pmiguel; 12-30-2011, 12:55 PM. Reason: Added detailed instruction for how not to be labelled "Junior Member"

    Leave a comment:


  • bertgold
    replied
    Incidentally, I resent this web site's assertion that I am a 'junior' member. I am 57 years old with more than 30 years of experience. I would hardly call myself 'junior'.

    Leave a comment:


  • bertgold
    replied
    It occurs to me that you probably centrifuge and aspirate the Ethanol. That will not work for the throughputs we are using.

    Yes, the CleanSeq at $ 20,000 per liter (appoximately) is far more expensive than the big dye per reaction.

    Leave a comment:


  • bertgold
    replied
    I am using 0.05 microliters big dye per well in 384 well plate. According to our numbers here that is less than 4 cents per well. I would happily use Ethanol instead of CleanSeq if it will really work. Beckman/Agencourt would hate that of course. Do you have a protocol I could adapt to an FX robot?

    Leave a comment:


  • pmiguel
    replied
    Originally posted by bertgold View Post
    Briefly, I want to say alot of the comparisons above are incorrect but I can't provide all details at this moment as I am in 'manuscript in preparation'. I am using 2 microliter reactions for big dye in a 384 well plate and am simultaneously giving these for 454. Final answers are not all in, but, the barcoding is not a problem, the big dye is working fine, and the real costs are the AmpPure, CleanSeq (on the Big Dye) and various kits needed for 454. I would happily to to MiSeq if anyone wants to offer me a machine. No, not send out. I have discovered in years of service that without absolute control of every parameter, perfecting new methods is a waste of time.
    Hi Bert,
    We just use ethanol to clean up Big Dye reactions. Is the CleanSeq really more expensive per reaction than the Big Dye itself? I mean with 2 ul sequencing reactions are you not pushing $2/reaction just in Big Dye costs?

    --
    Phillip

    Leave a comment:


  • bertgold
    replied
    not right imho

    Briefly, I want to say alot of the comparisons above are incorrect but I can't provide all details at this moment as I am in 'manuscript in preparation'. I am using 2 microliter reactions for big dye in a 384 well plate and am simultaneously giving these for 454. Final answers are not all in, but, the barcoding is not a problem, the big dye is working fine, and the real costs are the AmpPure, CleanSeq (on the Big Dye) and various kits needed for 454. I would happily to to MiSeq if anyone wants to offer me a machine. No, not send out. I have discovered in years of service that without absolute control of every parameter, perfecting new methods is a waste of time.

    PS- Anything written here is my personal 2 cents. ID info is provided for just that, ID only:

    Bert Gold, Ph.D., FACMG
    Staff Scientist
    Center for Cancer Research
    National Cancer Institute
    Boyles Street; Box B
    Fort Detrick
    Frederick, Maryland 21702
    Phone: 301-846-5098
    Fax: 301-846-7042
    E-Mail: [email protected]
    Website: http://ccr.cancer.gov/Staff/Staff.asp?profileid=7351

    Leave a comment:


  • niceday
    replied
    Thanks Phillip. I've been doing nextgen for a few years but have been asked to look at an established capillary setup to reduce costs.
    My first call is to seqanswers before I start spending money to save money.

    Leave a comment:


  • pmiguel
    replied
    For some applications we use 0.25 ul of Big Dye in a slightly less than 1/2 volume reaction. (7.5ul final volume). That puts us at 1/32nd reaction. I think we do about 120 cycles of themal cycling.

    ABI supplies their mysteriously named "5X buffer" -- you have to make up what you don't add in Big Dye with that. As of version 3.1 of Big Dye, just using a Tris and MgCl2 homemade buffer does not seem to work. Also, adding 5% DMSO, is no longer helpful -- in fact it appears to have negative effects.

    Okay, there are lots of other factors in play though. But basically it comes down to Big Dye being much "weaker" at 1/32nd reactions than at lesser dilutions. That is, contaminants that don't impact results at lesser dilutions are show stoppers at 1/32nd reactions. Generally these are the usual culprits: SDS, ethanol, etc. But at the higher dilutions, stuff like acetate (as in the sodium acetate you use a co-precipitant) are inhibiting the polymerase -- especially for long reads.

    So signal droop becomes your main enemy. That is, signal is strong at the beginning of the reaction, but drops to nothing a few hundred bases out. This is especially an issue, because you probably want to resuspend your reactions in water, not formamide, because water gives about 5x the signal of formamide. But water also favors shorter products during electrokinetic injection-- especially if there is any salt around.

    To counteract signal droop we had to reduce the amount of acetate coming in from the DNA prep by lowering the alcohol concentration for the DNA precipitation out of the lysate. That isn't enough, though. We also had to double the normal extension times for the sequencing reactions.

    As far as cost savings go, you need to have a sense of proportion. If you are spending 10% of you budget on the sequencing reaction and 90% on DNA preps and clean up reagents, then focus on lower the costs of DNA preps and reaction clean up reagents. There will be more "fat" there to be cut.

    Also, keep in mind that you want to push towards simplification, if possible. The simpler your protocol is, the fewer places there will be to make an error.

    Finally, if you are trying to save money: don't do Sanger sequencing. Find a way to use a next gen sequencer to accomplish your goals.

    --
    Phillip

    Leave a comment:


  • niceday
    replied
    Hi Pmiguel,

    You mentioned you were doing 1/32nd reactions. I'm assuming you are either diluting down, reducing the reaction volume or both.
    Are you able to give me any information on this?
    I have a bit of work to do and need to drive the cost down as much as possible.
    Thanks.

    Leave a comment:


  • TJK-OHSU
    replied
    Originally posted by pmiguel View Post
    Actually I think Sanger sequencing is a waste of money on any project that can be deployed on a next gen sequencer.

    The real problem is that it takes a lot of effort to convert Sanger sequencing methods over to Next Gen methods. Especially when you need to add in bar coding to pack enough projects into a single lane/region to make the buy in price for the project reasonable.
    --
    Phillip
    There are also the informatics and time per run factors to consider.

    Leave a comment:


  • TJK-OHSU
    replied
    Good points.The fact that you can increase the read depth using MP, essentially as high as you would like, does overcome the inherently higher error rate.

    Back to the relation of the two technologies though.
    The cost issue becomes calculation of the current cost per lane times the number of lanes needed to answer your question. ~60Kb, for now, seems to be a reasonable rule of thumb. Though as krobison points out, the PGM (Ion Torrent) may soon change that.
    When groups need to confirm variations found by MPS, they are working on a smaller region of interest, so the cost analysis favors Sanger sequencing, for now.

    Leave a comment:


  • pmiguel
    replied
    Actually I think Sanger sequencing is a waste of money on any project that can be deployed on a next gen sequencer.

    Current price for a 25,000 rxn kit BigDye Sequencing (Sanger sequencing) Kit from Applied Biosystems is right around $197,000. Now assume you are doing 1/32nd reactions. That makes a 25K kit capable of doing 800,000 reactions. Roughly $0.25/read -- just in Big Dye reagent. We ignore polymer, buffer, array, service contract -- all other costs. Lets give you 800 bases/read. That works out to $312.50 per megabase of sequence, just in Big Dye.

    Illumina gives sequence at around $0.10/megabase in reagents. (By the way, probably most price effective to do 2x100 paired end reads on ~400 bp fragment libraries.) A GS-FLX/GS-FLX+ around $10/megabase.

    The real problem is that it takes a lot of effort to convert Sanger sequencing methods over to Next Gen methods. Especially when you need to add in bar coding to pack enough projects into a single lane/region to make the buy in price for the project reasonable.

    --
    Phillip
    Last edited by pmiguel; 07-27-2011, 08:14 AM.

    Leave a comment:


  • krobison
    replied
    Originally posted by TJK-OHSU View Post
    Greetings,
    I'm trying to come up with a brief but fair description of the relationship of Sanger (CE) sequencing to Massively Parallel sequencing.
    Would you give me your take on this topic?
    Here's what I have so far:
    Briefly, a rule of thumb is that if the sequencing region of interest is < 60,000 bp than it is still cheaper to use the CE Sanger sequencing approach. Full "exome" capture and sequencing is currently ~$2,200 at the MPS Core. For that money you could sequence 88,000 bp at 5X coverage. You would have 800 nucleotide read lengths. So fairly easy assembly of the data to a reference sequence and very close to 99.99% accuracy. MPSequencing on the other hand gets ~75 nt read lengths, so assembly and mapping to a reference sequence is more difficult and accuracy, last I've read with >20X coverage is ~99.9%. So 1 error in 1000 bases instead of 1 error in 10,000 bases.
    It is for the latter reason that Sanger sequencing is used to validate sequence variants discovered with MPsequencing.
    In addition closing gaps between contigs (assembled shorter reads into longer contiguous regions) is usually accomplished with Sanger sequencing.
    While I think you are generally on the right track, you are muddying the waters by comparing exon capture + NGS to Sanger sequencing; in the first you seem to assume you don't yet have your target region but in the second you apparently have it cloned for Sanger. If you need to get at the target by PCR, then the cost of oligos & PCR must be included. You must also plan for PCR failures.

    For NGS, some other comparative numbers would be $1500-$2500 to do a single Ion Torrent run at a provider. If you had an instrument, the now $99 314 chip would be gross overkill for a 60Kbp fragment, and even with $200-400 or so in library prep costs would have a total cost below Sanger. There are also a number of outfits claiming to offer exomes down in the $1K range, though I suspect you need a large order for that.

    And because of the higher error rate for individual MP reads, the reads that are not "seen" multiple times are filtered out. This can make it more difficult to find variations that occur at a low frequency if not all cells contain the variation. E.g. looking for causative mutations in cancer research.
    If you have a mixed population of cells, as with cancer samples, Sanger is simply less sensitive. Unless your sample is 80+% tumor, your odds of finding heterozygous somatic mutations are quite poor with Sanger, but can be quite good with MPS. This is because the Sanger sequencing, unless you clone out individual products (more cost), gives a signal based on the population average -- if an allele is only 10% of the population it generates 10% signal, which will generally be missed with Sanger. Conversely, MPS techniques count individual molecules, and so the ability to detect rare mutations is a function of read depth and error rates. Detection of <1% mutations has been reported multiple times in the literature using 454 or Illumina.

    Leave a comment:

Latest Articles

Collapse

  • seqadmin
    Quality Control Essentials for Next-Generation Sequencing Workflows
    by seqadmin




    Like all molecular biology applications, next-generation sequencing (NGS) workflows require diligent quality control (QC) measures to ensure accurate and reproducible results. Proper QC begins at nucleic acid extraction and continues all the way through to data analysis. This article outlines the key QC steps in an NGS workflow, along with the commonly used tools and techniques.

    Nucleic Acid Quality Control
    Preparing for NGS starts with isolating the...
    Yesterday, 01:58 PM
  • seqadmin
    An Introduction to the Technologies Transforming Precision Medicine
    by seqadmin


    In recent years, precision medicine has become a major focus for researchers and healthcare professionals. This approach offers personalized treatment and wellness plans by utilizing insights from each person's unique biology and lifestyle to deliver more effective care. Its advancement relies on innovative technologies that enable a deeper understanding of individual variability. In a joint documentary with our colleagues at Biocompare, we examined the foundational principles of precision...
    01-27-2025, 07:46 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by seqadmin, 02-07-2025, 09:30 AM
0 responses
48 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-05-2025, 10:34 AM
0 responses
66 views
0 likes
Last Post seqadmin  
Started by seqadmin, 02-03-2025, 09:07 AM
0 responses
54 views
0 likes
Last Post seqadmin  
Started by seqadmin, 01-31-2025, 08:31 AM
0 responses
43 views
0 likes
Last Post seqadmin  
Working...
X